Malignant Mediastinal Neoplasm — Trials

Malignant Mediastinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 64
Recruiting: 37
Ph III recruiting: 1
Growth YoY: —
Industry share: 22%
Top sponsor: University of Washington
Termination share: 26.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01760226	Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies(DA-EPOCH-R)	completed	Early Phase 1	4	Baylor College of MedicineOTHER	1	Oct 14, 2025	clinicaltrials
NCT05208853	An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma	unknown	Early Phase 1	9	Zhejiang UniversityOTHER	1	Jan 26, 2022